Condray, Ruth Yao, Jeffrey K. Steinhauer, Stuart R. van Kammen, Daniel P. Reddy, Ravinder D. and Morrow, Lisa A. 2008. Semantic memory in schizophrenia: Association with cell membrane essential fatty acids. Schizophrenia Research, Vol. 106, Issue. 1, p. 13.
Nadalin, S. Rubeša, G. Giacometti, J. Vulin, M. Tomljanović, D. Vraneković, J. Kapović, M. and Buretić-Tomljanović, A. 2008. BanI polymorphism of cytosolic phospholipase A2 gene is associated with age at onset in male patients with schizophrenia and schizoaffective disorder. Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol. 78, Issue. 6, p. 351.
Isaac, Giorgis Fredriksson, Anders Danielsson, Rolf Eriksson, Per and Bergquist, Jonas 2006. Brain lipid composition in postnatal iron-induced motor behavior alterations following chronic neuroleptic administration in mice. FEBS Journal, Vol. 273, Issue. 10, p. 2232.
Sinclair, Andrew Wallace, Julie Martin, Marion Attar-Bashi, Nadia Weisinger, Richard and Li, Duo 2005. Healthful Lipids.
Skosnik, P.D. and Yao, J.K. 2003. From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?. Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol. 69, Issue. 6, p. 367.
Mahadik, Sahebarao P. Evans, Denise and Lal, Harbns 2001. Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 25, Issue. 3, p. 463.
Nishino, Seiji Mignot, Emmanuel Benson, Kathleen L and Zarcone, Jr, Vincent P 1998. Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture. Psychiatry Research, Vol. 78, Issue. 3, p. 141.
Horrobin, David F. Manku, Mehar S. Morse-Fisher, Nancy Vaddadi, Krishna S. Courtney, Paul Glen, A.Iain M. Glen, Evelyne Spellman, M. and Bates, C. 1989. Essential fatty acids in plasma phospholipids in schizophrenics. Biological Psychiatry, Vol. 25, Issue. 5, p. 562.
KAMMEN, DANIEL P. VAN YAO, JEFFREY K. and GOETZ, KENNETH 1989. Polyunsaturated Fatty Acids, Prostaglandins, and Schizophrenia. Annals of the New York Academy of Sciences, Vol. 559, Issue. 1 Arachidonie A, p. 411.
Stein, George Robertson, Mary and Nadarajah, Jayasheerie 1988. Toxic interactions between lithium and non-steroidal anti-inflammatory drugs1. Psychological Medicine, Vol. 18, Issue. 03, p. 535.
Caparrotta, L. Ceserani, R. Mongelli, N. Santi-Soncin, E. Ragazzi, E. and Fassina, G. 1987. Depression and exication induced in mice by two geometric isomers of (+)13,14-didehydro-20-methyl-carboprostacyclin, FCE 22177 and FCE 22176. Comparison with effects on blood pressure and platelet aggregation. Prostaglandins, Vol. 33, Issue. 3, p. 351.
Horrobin, David F. 1987. Essential Fatty Acids, Prostaglandins, and Alcoholism: An Overview. Alcoholism: Clinical and Experimental Research, Vol. 11, Issue. 1, p. 2.
Yeragani, V.K. and Chaitin, P. 1987. A prostaglandin theory of neuroleptic malignant syndrome. Medical Hypotheses, Vol. 24, Issue. 2, p. 143.
Mathe, Aleksander A. Eberhard, Göran Sääf, Jan and Wetterberg, Lennart 1986. Plasma prostaglandin E2 metabolite—measured as 11 -deoxy-15 -keto-13,14-dihydro-11 β, 16ξ-cyclo-PGE2—in twins with schizophrenic disorder. Biological Psychiatry, Vol. 21, Issue. 11, p. 1024.
Wilson, Donald W.S. and Douglass, Alan B. 1986. Niacin skin flush is not diagnostic of schizophrenia. Biological Psychiatry, Vol. 21, Issue. 10, p. 974.
Whalley, L. J. Reading, H. W. and Rosie, R. 1984. ADP and arachidonic acid induced platelet aggregation in schizophrenia and atypical psychoses. Psychological Medicine, Vol. 14, Issue. 01, p. 207.
Malek-Ahmadi, Parviz and Weddle, Margaret A. 1982. Schizophrenia and prostaglandins: Theories and therapeutic implications. General Pharmacology: The Vascular System, Vol. 13, Issue. 6, p. 467.
Ragheb, Mohamed and Ban, Thomas A. 1982. Prostaglandins and schizophrenia: A review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 6, Issue. 2, p. 87.
Rudin, Donald O. 1982. The dominant diseases of modernized societies as omega-3 essential fatty acid deficiency syndrome: Substrate beriberi. Medical Hypotheses, Vol. 8, Issue. 1, p. 17.
Mathé, A.A. Wiesel, F.A. Sedvall, G. and Nybäck, H. 1980. INCREASED CONTENT OF IMMUNOREACTIVE PROSTAGLANDIN E IN CEREBROSPINAL FLUID OF PATIENTS WITH SCHIZOPHRENIA. The Lancet, Vol. 315, Issue. 8158, p. 16.
Schizophrenia may be associated with increased prostaglandin synthesis in certain parts of the brain. This hypothesis is based on the following findings: (1) Catalepsy, which is the nearest equivalent in animals to human catatonia, develops in cats when prostaglandin E1 is injected into the cerebral ventricles and when during endotoxin or lipid A fever the prostaglandin E2 level in cisternal c.s.f. rises to high levels; however, when fever and prostaglandin level are brought down by non-steroid anti-pyretics which inhibit prostaglandin synthesis, catalepsy disappears as well. (2) Febrile episodes are a genuine syndrome of schizophrenia.
This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
Abstract views reflect the number of visits to the article landing page.
* Views captured on Cambridge Core between September 2016 - 28th May 2017. This data will be updated every 24 hours.